Back to Journals » Vascular Health and Risk Management » Volume 12
Review
Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
41,821 | Dovepress* | 14,253+ | 3,074 | 17,327 | |
PubMed Central* | 27,568 | 5,259 | 32,827 | ||
Totals | 41,821 | 8,333 | 50,154 | ||
*Since 17 February 2016 +Since July 2016 |
Total mentioned | Delicious | Others | |||
---|---|---|---|---|---|
30 | 0 | 0 | 0 | 14 | 16 |
View citations on PubMed Central and Google Scholar